Marie Alt

Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Esma Saâda-Bouzid, Cécile Defaucheux, Andy Karabajakian et al. · Annals of Oncology · 2017 · 596 citations

Oncology, Neoadjuvant Therapy, Anti-pd-1/pd-l1 Therapy +6

First-in-Human Phase I Study of Single-agent Vanucizumab, A First-in-Class Bispecific Anti-Angiopoietin-2/Anti-VEGF-A Antibody, in Adult Patients with Advanced Solid Tumors

Manuel Hidalgo, Maria Martinez‐García, Christophe Le Tourneau et al. · Clinical Cancer Research · 2017 · 99 citations

Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer: cross-over analysis from the SHIVA trial

Lisa Belin, Maud Kamal, Cécile Mauborgne et al. · Annals of Oncology · 2016 · 83 citations · Full text

Medicine, Versus Conventional Therapy, Clinical Trials +11

Relevance of a molecular tumour board (MTB) for patients’ enrolment in clinical trials: experience of the Institut Curie

Clémence Basse, Claire Morel, Marie Alt et al. · ESMO Open · 2018 · 55 citations · Full text

Contrast-Enhanced Power and Color Doppler Ultrasonography of the Pancreas in Healthy and Diseased Cats

Nathalie Rademacher, Stefanie Ohlerth, G. Scharf et al. · Journal of Veterinary Internal Medicine · 2008 · 47 citations · Full text